Pattern-based forward bias: Similar-pattern stats imply weak next-day/-week drift but better 1-month upside (notable positive skew over the next month).
Activity: Today’s options volume 421 with call volume 388 vs put volume 33 (call-dominant).
Volatility: IV (30d) ~99.34 vs historical vol ~64.12; IV percentile ~89.56 suggests options are pricing large moves and traders are paying up for convexity.
Interpretation for stock: Call-skew supports upside bias, but elevated IV often coincides with bigger swings around macro/oil moves and upcoming events.
Technical Summary
Sell
1
Buy
11
Positive Catalysts
Street narrative improved materially after the Eagle Ford asset sale and the resulting balance sheet reset (debt reduction capacity + potential for more shareholder returns).
Multiple upgrades to Outperform/Buy with higher price targets suggest institutional confidence in the post-transaction strategy.
Upcoming earnings (2026-03-05, after hours) can act as a catalyst if cash flow/buyback commentary is strong.
Technical backdrop remains supportive (bullish MA stack + improving MACD).
Neutral/Negative Catalysts
showed sharp profitability deterioration** (Net Income and EPS down ~83% YoY), which can cap near-term enthusiasm.
Net Income $32.0M, -82.74% YoY (major earnings compression).
EPS $0.04, -82.61% YoY.
Gross Margin 34.44%, -10.48% YoY.
Takeaway: operational/commodity headwinds hit results in 2025/Q3, but the strategic asset sale and balance-sheet improvement are the market’s primary forward focus.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Trend: Ratings turned more bullish with a cluster of upgrades and higher targets following the Eagle Ford divestment.
Key changes:
BMO upgraded to Outperform, PT raised to C$6 (from C$3).
Scotiabank upgraded to Outperform, PT raised to C$5.25 (from C$4).
Raymond James upgraded to Outperform, PT raised to C$5.50 (from C$3.50).
TD Securities reiterated Buy, PT raised to C$5 (from C$4.75).
Wall Street pros: cleaner Canadian-focused portfolio, stronger balance sheet, higher-return asset base, greater capacity for buybacks.
Wall Street cons: recent YoY financial declines highlight sensitivity to commodity pricing and margins; execution risk in delivering improved returns post-portfolio shift.
Wall Street analysts forecast BTE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTE is 3.62 USD with a low forecast of 2.88 USD and a high forecast of 4.32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast BTE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTE is 3.62 USD with a low forecast of 2.88 USD and a high forecast of 4.32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 3.390
Low
2.88
Averages
3.62
High
4.32
Current: 3.390
Low
2.88
Averages
3.62
High
4.32
TD Securities
NULL
to
Buy
maintain
$5
AI Analysis
2025-12-23
Reason
TD Securities
Price Target
$5
AI Analysis
2025-12-23
maintain
NULL
to
Buy
Reason
TD Securities raised the firm's price target on Baytex Energy to C$5 from C$4.75 and keeps a Buy rating on the shares.
Raymond James
Raymond James
Market Perform -> Outperform
upgrade
2025-11-13
Reason
Raymond James
Raymond James
Price Target
2025-11-13
upgrade
Market Perform -> Outperform
Reason
Raymond James upgraded Baytex Energy to Outperform from Market Perform with a price target of C$5.50, up from C$3.50, after the company announced the sale of its U.S. Eagle Ford assets to an undisclosed buyer for $3.25B. The deal repositions Baytex into a "high-return" Duvernay and heavy oil producer with a "best-in-class" balance sheet, the analyst tells investors in a research note. Raymond James says the sale is immediately accretive while providing Baytex with enough capital to repay all of its outstanding debt and shift focus to an "aggressive" share repurchase program.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BTE
